|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | What is the role of quality circles in strategies to optimise antibiotic pre- scribing A pragmatic cluster-randomised controlled trial in primary care显示文摘 | Van Driel ML Coenen S Dirven K | 2007 | Qual Saf Health Care2007，16，3： | 1 |
| 2 | Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma prreumon/ae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the 'Gold Standard' 显示文摘 | BEERSMA M F C DIRVEN K van DAM A P | 2005 | J Clin Microbiol2005，43，5： | 1 |
| 3 | The assessment of pharyngo- cutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypo- pharynx 显示文摘 | Dirven R Swinson B D Gao K | 2009 | Laryngoscope2009，119，9： | 1 |
| 4 | Evaluation of 12 commercial test and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G( IgG )and IgM anfibodis, with PCR used as the 'gold standard' 显示文摘 | Beersma MF Dirven K van Dam AP | 2005 | Clin Microbiol2005，43，5： | 1 |
| 5 | Quality indicators for type -2 diabetes care in practice guidelines: an example from six European countries显示文摘 | Wens J Dirven K Mathieu C | 2007 | Prim Care Diabetes2007，1，1： | 1 |
| 6 | Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (lgG) and IgM antibodies, with PCR used as the 'gold standard' 显示文摘 | Beersma M F Dirven K Van-Dam A P | 2005 | J Clin Microbiol2005，43，5： | 1 |
| 7 | The assessment of pha-ryngocutaneous fistula rate in patients treated primarily with de-finitive radiotherapy followed by salvage surgery of the larynx and hypopharynx显示文摘 | Dirven R Swinson BD Gao K | 2009 | Pharyngocutaneous Fistula Rate Laryngo-scope2009，119，9： | 1 |
| 8 | Evaluation of 12 commercial tests and the complement fixation test for Mycoplas- ma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the'gold standard' 显示文摘 | Beersma MF Dirven K van Dam AP | 2005 | J Clin Mi- crobiol2005，43，5： | 1 |
| 9 | Evaluation of 12 eanmercial test and the complement fixation test for Mycoplasma pneumoniae - specific immunoglobulin G (IgG) and lgM antibodies ,with PCR used as the 'gold standard' 显示文摘 | Beersma MF Dirven K van Dam AP | 2005 | Clin Microbiol2005，43，5： | 1 |
| 10 | Evaluation of12commercial tests and the complement fixztion test forMycoplasma pneumoniae specific immunoglobulin G(IgG)and IgM antibodies,with PCR used as the 'gold standard'显示文摘 | Beersma MF Dirven K Van Dam AP et a/ | 2005 | J Clin Microbiol2005，43，5： | 1 |
| 11 | Evaluation of 12 commercial tests and the complement fixation test formycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the Tgold standardr 显示文摘 | Beersma MF Dirven K van DAP | 2005 | J Clin Microbiol2005，43，5： | 1 |
| 12 | The assessment of pha- ryngocutaneous fistula rate in patients treated primarily with de- finitive radiotherapy followed by salvage surgery of the larynx and hypopharynx 显示文摘 | Dirven R Swinson BD Gao K | 2009 | Pharyngocutaneous Fistula Rate Laryngo- scope2009，119，9： | 1 |
| 13 | Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies,with PCR used as the 'gold standard'显示文摘 | Beersma MF Dirven K van Dam AP | | 0，，05： | 1 |
| 14 | Evaluation of 12commercial tests and the complementary fixation test for my-coplasma pneumoniae-specific imunoglobulin G(IgG)and IgMantibodies,with PCR used as the“gold standard”显示文摘 | Beersma MF Dirven K Van Dam AP | 2005 | J ClinMicrobiol2005，43，5： | 1 |
| 15 | Evaluation of 12 commercial test and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G(IGG) and IGM antibodis,with PCR used as the 'gold standard'显示文摘 | Beersma MF Dirven K van Dam AP | | 0，，05： | 1 |
| 16 | Detection of mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition control显示文摘 | Ursi D Dirven K Loens K | 2003 | Microbiol Methods2003，55，1： | 1 |
| 17 | Q1Jality jnddcators for type-2 diabetes care in practice guidelines:an example from six Euro- pean countries显示文摘 | Wens J Dirven K Mat]eu C | 2007 | Prim Care Diabetes2007，1，： | 1 |
| 18 | Evalustion of 12 commer- cial tests and the complement fixation test for Mycoplasma pneumoniae specific immunoglobulin G (IgG) and lgM antibodies, with PCR used as the 'gold standard' 显示文摘 | Beersma MFC Dirven K Van Dam AP | 2005 | J Clinical Microbiology2005，43，5： | 1 |
| 19 | Evaluation of 12 commercial tests and the complement fixation test for mycoplasma pneumpniae specific immunoglobulin G(IgG)and IgM antibodies,with PCR used as the'gold standard'显示文摘 | Beersma MFC Dirven K Van Dam AP | | 0，，05： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员